HS Code Subheading

Cell cultures, whether or not modified; cell therapy products

3002.51 Subheading
Section VI — Products of the chemical or allied industries

About HS Code 300251

This HS code specifically covers cell cultures, whether or not modified, and cell therapy products. This represents a cutting-edge and rapidly expanding segment of the biopharmaceutical industry, focusing on advanced therapies that use living cells to treat diseases. Products range from human mesenchymal stem cells and CAR-T cells for cancer treatment to various cell lines used in drug discovery and regenerative medicine research. International trade in these highly sensitive biological products demands extremely specialized logistics, including ultra-cold chain management, and stringent regulatory compliance, particularly for therapeutic applications (e.g., FDA, EMA approvals). Importers and exporters include biopharmaceutical companies, contract manufacturing organizations, hospitals, and research institutions, all navigating complex ethical and safety considerations.

Products Under This Code

Human mesenchymal stem cells, CAR-T cells, Induced pluripotent stem cells (iPSCs), Fibroblast cell lines, Therapeutic cell lines, Hematopoietic stem cells, Chondrocyte cultures

Real World Examples

Kymriah (Novartis CAR-T therapy), Yescarta (Gilead CAR-T therapy), specific cell lines from Lonza, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific cell culture media

Common Misclassification

This code could be confused with other biological products like blood fractions (3002.12) or even tissues for transplantation, though the latter are typically classified differently.

Products Classified Under 3002.51

Cell therapy products

Related Codes

3002.12 Blood, human or animal, antisera, other blood fractions and immunological products; antisera and other blood fractions 3002.13 Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale 3002.14 Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, mixed, put up in measured doses or in forms or packings for retail sale 3002.15 Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, put up in measured doses or in forms or packings for retail sale 3002.41 Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; for human medicine 3002.42 Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; for veterinary medicine 3002.49 Toxins, cultures of micro-organisms (excluding yeasts) and similar products; n.e.c. in item 3002.3 3002.59 Cell cultures, whether or not modified; other cell cultures not including cell therapy products 3002.90 Toxins, cultures of micro-organisms (excluding yeasts) and similar products

Industry

This code belongs to the Chemicals industry.

Trade Overview

The USA, EU, and Japan are leaders in cell therapy development and manufacturing, with global importers for clinical trials and treatment.

Frequently Asked Questions

What is HS code 300251?

HS code 300251 covers: Cell cultures, whether or not modified; cell therapy products. This HS code specifically covers cell cultures, whether or not modified, and cell therapy products. This represents a cutting-edge and rapidly expanding segment of the biopharmaceutical industry, focusing on advanced therapies that use living cells to treat diseases. Products range from human mesenchymal stem cells and CAR-T cells for cancer treatment to various cell lines used in drug discovery and regenerative medicine research. International trade in these highly sensitive biological products demands extremely specialized logistics, including ultra-cold chain management, and stringent regulatory compliance, particularly for therapeutic applications (e.g., FDA, EMA approvals). Importers and exporters include biopharmaceutical companies, contract manufacturing organizations, hospitals, and research institutions, all navigating complex ethical and safety considerations.

What products fall under HS code 300251?

Human mesenchymal stem cells, CAR-T cells, Induced pluripotent stem cells (iPSCs), Fibroblast cell lines, Therapeutic cell lines, Hematopoietic stem cells, Chondrocyte cultures

What are common misclassifications for HS code 300251?

This code could be confused with other biological products like blood fractions (3002.12) or even tissues for transplantation, though the latter are typically classified differently.

How is HS code 300251 structured?

HS code 300251 is a 6-digit subheading under the Harmonized System. The first 2 digits (30) identify the chapter, digits 3-4 (02) identify the heading, and digits 5-6 (51) specify the subheading. This code is standardized globally by the World Customs Organization.